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ABSTRACT 
OBJECTIVES: To investigate how cardio-metabolic-inflammatory risk factors are related to 
cognition among older adults in India and the United States.  
DESIGN: The Longitudinal Aging Study in India – Diagnostic Assessment of Dementia (LASI-
DAD) and the Harmonized Cognitive Assessment Protocol of the Health and Retirement Study 
(HRS-HCAP) in the United States conducted an in-depth assessment of cognition, using 
protocols designed for international comparison.  
SETTING: Cognitive tests were conducted in hospital or household settings in India and in 
household settings in the United States.  
PARTICIPANTS: Respondents aged 60 and older from LASI-DAD (N=1,865) and respondents 
aged 65 and older from HRS-HCAP (N=2,111) who provided venous blood specimen.  
MEASUREMENTS: We used total composite scores from the common cognitive tests 
administered. Cardiovascular risk was indicated by systolic and diastolic blood pressure, pulse 
rate, pro-B-type-natriuretic-peptide (proBNP), and homocysteine. Metabolic risk was measured 
by body mass index, glycosylated hemoglobin (HbA1c), HDL-cholesterol, and lipoprotein (a) 
(only in India). Inflammatory risk was indicted by white blood cell count, C-reactive protein, 
albumin, and uric acid (only in India). 
RESULTS: The distribution of both total cognition scores and of cardio-metabolic risk factors 
differed significantly between India and the United States. In both countries, lower cognition was 
associated with older age, lower education, elevated homocysteine, elevated proBNP, and lower 
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albumin levels. The associations between HbA1c levels and cognitive measures were statistically 
significant in both countries, but in the opposite direction, with a coefficient of 1.5 (p<0.001) in 
India and -2.4 (p<0.001) in the United States for one percentage increase in absolute HbA1c 
value. 
CONCLUSION: Cardio-metabolic-inflammatory biomarkers are associated with cognitive 
functional levels in each country, but the relationships may vary across countries.  
 
Key words: dementia risk factors, Harmonized Cognitive Assessment Protocol, Longitudinal 
Aging Study in India, Health and Retirement Study, international comparisons   
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INTRODUCTION 
Dementia has become an important public health and socioeconomic challenge in India 
as well as in the United States.1,2 Because of population aging, the prevalence of dementia will 
continue to increase in both countries, leading to higher medical and personal care expenses, 
decreased functioning and quality of life for affected individuals, and stress and loss of 
productivity for family caregivers. With ongoing population aging, it is estimated that the 
number of worldwide dementia cases will triple by 2050.3 
Cardio-metabolic diseases may increase the risk for cognitive decline and dementia 
through multiple causal pathways, including direct effects on neurons, hypoperfusion due to 
reduced cerebral blood flow, and promotion of amyloid cascade.4 Cardiovascular disease may 
also alter epithelium cells, which dislocate blood brain barrier, resulting in disturbance in 
amyloid clearance. India has been undergoing a significant change in disease burden with swift 
increase in cardiovascular and metabolic diseases. Data from the Global Burden of Diseases, 
Injuries, and Risk Factors Study indicated that cardiovascular diseases accounted for 28.1% of 
the total deaths in India in 2016, compared with 15.2% in 1990.5 However, this epidemiological 
transition is occurring decades later than that in the United States. Indians appear to have a 
unique “South Asian phenotype” with high propensity for metabolic syndrome, insulin 
resistance, greater degree of central obesity as well as a high prevalence of hypertension at 
relatively young ages.6 In addition, there appears to be suboptimal management of cardio-
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metabolic diseases in India with only 10.7% of rural hypertension patients and 20.2% of urban 
patients having their blood pressure under control.7,8  
This study provides an analysis of how risk factors – biological and sociodemographic – 
relate to cognitive functioning in a representative sample of Indians over the age of 60 and 
compares the results to those in a representative sample of Americans aged 65 and above. This 
comparison offers a unique opportunity to compare and contrast how cardio-metabolic risk 
factors are related to cognitive functioning in these two populations. One has virtually complete 
literacy and the other has a large non-literate component. The marked difference in educational 
levels between older Indians and older Americans leads to significant differences in late life 
cognition. In addition, the American older population has had extensive medical care throughout 




The study population in India is participants of the Longitudinal Aging Study in India – 
Diagnostic Assessment of Dementia (LASI-DAD) Study. The details of study design and 
methodology have been described in this special issue.9 LASI-DAD, a subsample from the 
population-representative Longitudinal Aging Study in India (LASI), was established to provide 
a more accurate prevalence estimate of dementia at the national level and study key risk factors 
associated with cognitive decline and dementia in India. It recruited 3,224 LASI participants 
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aged 60 years and above with oversampling of those at high risk of cognitive impairment. To 
facilitate cross-country comparisons, LASI-DAD adopted the protocol from the Health and 
Retirement Study Harmonized Cognitive Assessment Protocol Project (HRS-HCAP) to assess 
cognitive function and modified where necessary, considering India’s higher illiteracy and 
innumeracy as well as cultural context.  
The details about HRS-HCAP have been published previously.10 Briefly, the HRS is an 
ongoing nationally-representative panel study of about 20,000 adults aged 51 or older in the 
United States. HRS-HCAP is a sub-study within HRS designed to better measure and identify 
cognitive impairment and dementia in a representative population-based sample of U.S. adults 
aged 65 and above. It interviewed the target HRS respondents as well as informants nominated 
by respondents when self-response was not possible. The HRS-HCAP cognitive test battery was 
designed to measure a range of key cognitive domains affected by cognitive aging and to allow 
harmonization and comparisons to other studies in the United States and around the world.  
For this analysis, we included 1,865 individuals from LASI-DAD and 2,111 individuals 
from HRS-HCAP. Among 3,224 initial LASI-DAD respondents, 2,254 respondents provided 
venous blood specimen (VBS) samples. We lost 139 respondents who were missing in various 
VBS assays including pro-B-type-natriuretic-peptide (proBNP), C-reactive protein (CRP), 
albumin, homocysteine, HDL cholesterol, glycosylated hemoglobin (HbA1c), and white blood 
cell count (WBC). In addition, we lost 250 respondents due to missing body mass index (BMI), 
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pulse rate, systolic and diastolic blood pressure. The details of venous blood collection and assay 
protocol are described in Dey et al.11 available on the project website (www.lasi-dad.org).  
A total of 3,347 HCAP participants attempted the cognitive testing. Of these, 3,210 had 
complete data on all the tests used here, and another 124 had nearly complete data for which 
imputation was done for missing tests using the performance on all other tests. We excluded 13 
for incomplete data on cognition and about 340 because they did not have complete data on 
blood tests from the 2016 whole blood draw. In addition, we dropped about 900 because they did 
not have data from the HRS 2014 or HRS 2016 home visit which was used for data on blood 
pressure, pulse, and BMI. For a total of 229 persons in the remaining sample of 2,111 we 
imputed a missing value of HbA1c based on their fasting plasma glucose using the relationship 
between the two observed in the cases with both measures.   
Comparing respondents who had missing information with those who had complete data, 
we found that, in India, missingness was associated with being 75 years or older, having no 
education, and living in a rural area; in the United States, being missing was associated with 
being 75 years or over and being female. In each country, these predictors explained only 1% of 
the variance in missingness. 
 
Measures 
Cognitive function measure 
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 For cross-country comparisons, we used a harmonized total cognitive score, which 
provides a comprehensive assessment of various cognitive domains. The total cognitive score is 
a summary score based on the following tests: 10-word learning, including immediate and 
delayed recall and recognition12; logical memory (i.e., Brave Man story only), including 
immediate and delayed recall and recognition13; Mini Mental State Exam (MMSE)14 or a 
validated Hindi version of MMSE (HMSE) summary score15; verbal fluency score,16 which was 
the number of named animals within 60 seconds; the community screening instrument for 
dementia (CSID) score17; and Raven's test,18 a count of the number of correct answers to a series 
of images that required the respondent to select the missing piece. The range of total cognitive 
scores was from 0 to 175 (see Table 2 for the range and mean for each component test). 
We imputed information for missing values in the cognitive tests. The implemented 
method used for the Indian data was inspired by the imputations of cognition variables used in 
the HRS.19 In a nutshell, this imputation method replaces missing values with random draws 
from a conditional distribution such that the estimated joint distribution from the completed 
(imputed) data is an unbiased estimator of the true joint distribution of these variables. The 
conditional distribution for each test score is obtained by regressing the to-be-imputed test score 
on other, previously imputed test scores, as well as demographic, health, and socioeconomic 
variables. Further details of imputation strategy are described in another paper in this issue.20 
Imputation has not yet been done on the available HRS-HCAP data; for this analysis, we 
imputed data for the 124 cases using a conventional nearest neighbor approach.   
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Cardio-metabolic-inflammatory biomarkers 
Both LASI-DAD and HRS-HCAP conducted face-to-face computer-assisted personal 
interviews (CAPI) on respondents and their informants, measured anthropometric and physical 
parameters, and collected venous blood for laboratory tests, including those related to cardio-
metabolic-inflammatory diseases. 
Cardiovascular system: Biomarkers included high blood pressure defined as systolic 
blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, pulse rate, proBNP, and 
homocysteine. At-risk proBNP was defined as a level of ≥ 900 pg/mL for 50-74 year-olds, and ≥ 
1,800 pg/mL for ≥ 75 years-old. These cut-off points are usually used to diagnose congestive 
heart failure (CHF).21,22 
Metabolic system: Biomarkers included BMI based on measured height and weight (self-
reported if measured height and weight are not available), glycosylated hemoglobin (HbA1c), 
HDL-cholesterol, and lipoprotein (a) (which was not available in HRS). In HRS-HCAP, we have 
imputed HbA1c for those who have glucose in the VBS data but no value for HbA1c. Imputation 
was done separately for fasting and non-fasting samples. Because LASI-DAD had a significant 
percentage of non-fasting participants at the time of blood collection, we did not include glucose, 
LDL-cholesterol, and triglycerides in this analysis.  
Inflammatory system: Biomarkers included white blood cell count (WBC), C-reactive 
protein (CRP), albumin (a negative acute-phase reactant), and uric acid. 
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Covariates 
Demographic characteristics included age and sex. Education was included as a 
categorical variable with three categories for the United States (0-11, 12, 13+ years) and four 
categories for India (0, 1-11, 12, 13+ years). The extra category for India is because a large 
proportion of older population has no formal education while this is not true in the United States. 
Household wealth was also included as a categorical variable based on quintile distribution. 
 
Statistical Approach 
 We use multivariate ordinary least squares regression analysis with the cognitive measure 
as the outcome variable. There are three equations for each country. The first includes cardio-
metabolic-inflammatory biomarkers only, the second adds age and sex, and the third adds 
education and household wealth. Comparison of these equations allows us to assess how the 
biomarkers are associated with cognitive function, independent of sociodemographic 
characteristics. In addition, we can assess how much of the variability in the outcomes is 
explained by these variables when we compare the R2 of the three equations. 
We examined the intercorrelations among all the biomarkers and found high correlation 
coefficients only between systolic and diastolic blood pressure values. As a result, we defined 
high blood pressure as either systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 
90 mmHg, and included this dichotomous variable in the models. To assess possible non-linear 
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relationships, we categorized four variables in the regression analysis: age (60-64, 65-69, 70-74, 
and 75 years and above); BMI (<18.5 kg/m2, 18.5-24.9 kg/m2, 25-29.9 kg/m2, and ≥ 30 kg/m2); 
and education and household wealth as described above. Other cardio-metabolic-inflammatory 
biomarkers were included as continuous variables in the models. Log transformations were done 
for WBC, CRP, and proBNP due to significant right-skewed distributions. To explore potential 
effects from residual confounding, we have also conducted a sensitivity analysis among HRS 
participants to include race/ethnicity as a covariate. 
 
RESULTS 
The characteristics of the samples are summarized in Table 1. The two populations 
differed markedly in age and education. The Americans were much older, with no members of 
the cohort less than 65 years, while about 28% of the Indians were of this age, and many more 
Americans were 75 or older, about 41% in the United States and 23% in India (Table 1). Almost 
half (46%) of the Indian sample had no formal schooling, while 84% of the American cohort had 
at least a high school education as did only 8% of the Indian cohort. The percent of the sample 
with high-risk levels of most of the cardiovascular and metabolic risk factors was higher in India 
than in the United States. The notable exception was BMI: less than one third of Indians and 
more than three-fourths of Americans were overweight. The prevalence of elevated measured 
blood pressure was significantly higher in India than in the United States: both systolic and 
diastolic blood pressures were more likely to be elevated in India. Although more Indians had 
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HbA1c equal to or higher than 6.5%, the distribution of HbA1c values was fairly similar in the 
two countries. The prevalence for high homocysteine levels was three times higher in India than 
in the United States and adverse levels of HDL (low levels) were much higher in India than in 
the United States. As indicated above, we used age-specific cut-off points for CHF to define high 
proBNP, which are ≥ 900 pg/mL for those between ages 60 and 74, and ≥ 1,800 pg/mL for those 
≥ 75 years-old. The prevalence of high-risk proBNP levels was quite similar between India and 
the United States. Prevalence of elevated levels of CRP, an indicator of overall systemic 
inflammation, was fairly similar in two countries.   
 Figure 1 shows distribution of total cognitive scores for the two countries. It is clear that 
the scores are much higher in the United States than in India. Because educational attainment 
differs so much in the two populations and has been shown to be so highly related to cognitive 
functioning, we also examine mean total cognitive scores by education levels in the two 
countries (Figure 2). The data confirmed that cognitive functioning score increased with more 
education. However, even though the whole sample of Indians had significantly lower total 
cognitive scores than Americans, at the same education level these differences were relatively 
small between the two countries. This pattern of similar education-specific cognitive 
performance was observed in all individual components of the total cognitive score (Table 2). 
For example, the mean MMSE score was 27.0 for Indians with 12 years of education and 26.9 
for Americans at same education level. For those with 13 years of education and above, the mean 
MMSE score was identical at 28.1 for both countries. Because HRS-HCAP had very few 
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respondents without any formal education, we were not able to do cross-country comparison of 
cognitive performance among illiterate individuals.   
Multivariate regression analysis indicates that the cardiovascular biomarkers most 
consistently associated with cognitive function in both countries were homocysteine and 
proBNP. The associations were negative for both measures. They were also fairly similar in 
coefficient size with proBNP of -3.3 in India and -2.8 in the United States; and for homocysteine, 
the coefficients were -0.1 and -0.6, respectively (Table 3, Model 1). The associations between 
HbA1c and the cognitive measure were also significant, but in the opposite direction between 
India and the United States, with a regression coefficient of 1.5 in India and -2.4 in the United 
States for one percentage increase in absolute HbA1c value. This pattern did not change after 
including quadratic and cubic terms of HbA1c in the regression equation or categorizing HbA1c 
values into < 5.7%, 5.7-6.4%, and ≥ 6.5%. BMI was associated with cognitive function in India, 
with people with higher BMI performing better, including those in the range of obesity. On the 
other hand, low BMI (< 18.5 kg/m2) was not significantly associated with poor cognitive 
functioning but obesity (BMI ≥ 30.0 kg/m2) was related to better cognitive functioning among 
Americans. Among inflammatory markers, albumin was consistently and positively associated 
with cognitive function in both countries. 
Older age and lower educational attainment were independently associated with lower 
total cognitive scores in both Indians and Americans (Table 3, Models 2 and 3). Compared to 
those with less than 12 years of education, the mean total cognitive scores were 19.3 points lower 
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among Indians who were illiterate, 4.5 points higher among Indians who completed high school, 
and 13.2 points higher among those who had at least some college. Among Americans, the 
difference in total cognitive scores among those with higher education levels were 13.0 and 20.1 
points, respectively. Compared to males, female scored lower in India but higher in the United 
States, although this sex-difference in India was not statistically significant after controlling for 
education and wealth. 
After sociodemographic variables were added to the models, the associations of total 
cognitive scores with proBNP, homocysteine, BMI, and HbA1c remained statistically significant 
(Table 3, Model 3), although the strength of associations decreased. For example, the 
coefficients for higher proBNP decreased from -3.3 to -1.4 in India and from -2.8 to -1.4 in the 
United States.   
 R-square values from the analysis indicate that a greater proportion of the variance in 
total cognitive scores was explained in India than in the United States (0.41 versus 0.32). R-
squares for cardio-metabolic-inflammatory biomarkers alone were 0.18 in India and 0.10 in the 
United States. Addition of education levels and household wealth significantly improved our 
ability to predict cognitive function in both countries. 
 To assess the effects of other potential confounding variables, we conducted a sensitivity 
analysis among HRS participants to include race/ethnicity, an important correlate of cognitive 
functioning in the United States. Adding race/ethnicity only increases the variance explained by 
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1%. It reduces the magnitude of effects for glycosylated hemoglobin and albumin, so that they 
are no longer significantly associated with cognitive functioning. 
 
DISCUSSION  
In this analysis of the associations between cognitive function and cardio-metabolic-
inflammatory risk factors, our data showed that several cardio-metabolic-inflammatory risk 
factors were independently associated with cognitive functional levels. Cognitive functioning 
was lower among those with high homocysteine and proBNP levels, and among those with low 
albumin levels in both countries. The association between HbA1c and cognitive measure was 
consistently significant, but in the opposite direction between the two countries, negative in the 
United States and positive in India. The link between weight and cognition seems strong in India, 
with a clear pattern of higher weight and better cognition; while in the United States only those 
with obesity have better cognition than those in the normal range. 
 Studies of older adults in many countries have shown that lower educational levels 
predict worse global cognitive functioning.23-26 Education attainment is a well-established 
indicator of cognitive reserve capacity in older people and may have a direct effect on cognition 
through more developed and effective use of brain networks or cognitive paradigms.27 Our 
analysis extends previous findings by demonstrating that, across two countries with very 
different distributions of education attainment, the difference in cognitive functioning is 
relatively small when we compare individuals with similar education levels. This observation 
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appears true for both overall cognitive functioning as well as many of the individual domains 
(Table 2 and Figure 2).  
 In addition to the direct effect of education on cognition, years of formal education may 
also be a surrogate for other factors that might influence cognition, including development and 
management of cardiovascular and metabolic diseases. The proposed causal pathways through 
which cardio-metabolic diseases lead to cognitive decline and dementia include direct damage of 
neurons, cerebral blood hypoperfusion, and promotion of amyloid cascade.4 Our finding of an 
inverse association between cognitive function and homocysteine and proBNP levels is 
consistent with previous research. In a prospective cohort of individuals 75 years and above, 
Blasko et al. reported that increased homocysteine levels were independently associated with 
decline of cognitive performance in normal older subjects and patients with Alzheimer’s 
disease.28 It has been postulated that homocysteine plays a role in promoting oxidative stress, 
inflammation, thrombosis, endothelial dysfunction, and cell proliferation.29 Earlier studies in 
developed countries also showed that both cross-sectionally measured proBNP levels and 
increase in proBNP levels are related to subsequent risk of cognitive decline and dementia, 
mostly because of the association between proBNP levels and macro- and micro-ischemic 
changes of brain.30-32 Our study confirmed the same relationship between adverse cardiovascular 
biomarkers and cognitive decline in India. The inverse association with homocysteine might be 
particularly relevant, because two-thirds (67.1%) of the Indian study population had at-risk 
homocysteine levels (Table 1). 
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 HbA1c level is a measure of average glucose metabolism during the previous 3 months, 
and has been used clinically to diagnose diabetes mellitus and monitor glucose control. A recent 
meta-analysis indicates that poorer glycemic control is related to cognitive dysfunction.33 
However, we found that, unlike Americans, Indians with higher HbA1c levels actually had 
higher total cognitive scores. This may reflect different stages of epidemiological transition for 
these two countries. With more recent economic development, Indians with higher 
socioeconomic status are more likely to adopt a western diet and have decreased level of 
physical activities, leading to a higher prevalence of non-communicable diseases. Previous 
analysis has shown that obesity and hypertension are more common among LASI participants 
who have higher education level, while these medical conditions are less common among 
Chinese older adults with better education.34 Therefore, the positive association between HbA1c 
levels and cognitive function in India highlights the complexity of how cardio-metabolic-
inflammatory risk factors may influence cognitive decline in countries that are undergoing rapid 
economic and societal transitions. 
 This study has some important strengths. LASI-DAD and HRS-HCAP are nationally 
representative samples of older adults in the two countries. Both studies generated high quality 
cognitive functioning and biomarker data. More importantly, cognitive assessment protocols 
were harmonized conceptually to allow more accurate cross-country comparisons. Several 
limitations should also be noted. First, even though LASI-DAD and HRS-HCAP are designed as 
longitudinal studies, our current analysis is cross-sectional. It does not allow us to examine the 
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temporal relationship between cognitive function and cardio-metabolic-inflammatory risk 
factors. It is possible that the association works in both directions, as severe cognitive decline 
may affect management of cardio-metabolic diseases, causing more pathophysiological 
dysfunction. Second, only 32% of LASI-DAD respondents provided fasting blood specimens – 
limiting our ability to examine biomarkers that typically require fasting specimens (e.g., LDL 
cholesterol) or to formally define metabolic syndrome. Third, some of the cardio-metabolic-
inflammatory biomarkers may be indicators for more than one system. For example, 
homocysteine is associated with cardiovascular disease, but its level also goes up in the setting of 
folate or vitamin B12 deficiency. Lastly, even though we adjusted for categories of age, sex, 
education and wealth, residual confounding remains a possibility.  
 Despite these limitations, this cross-country study sheds a new insight to the relationships 
between cognition and cardio-metabolic-inflammatory risk factors in two countries, India and the 
United States. Lower cognitive function is associated with older age, lower educational 
attainment, elevated homocysteine, elevated proBNP, lower albumin levels, and lower body 
mass index in both countries. The associations between HbA1c and cognitive measure are 
consistently significant, but in opposite direction between India and the United States. 
Longitudinal data from the future waves of LASI-DAD and HRS-HCAP will enable us to further 
investigate how changes in biomarkers are related to changes in cognitive function. These 
longitudinal analyses could provide more insight on biological pathways for cognitive decline 
and to explore potential interventions aimed at reducing cognitive decline and dementia. 
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Table 1. Comparison of select sample characteristics between LASI-DAD (N=1,865) and HRS-
HCAP (N=2,111)  
Variables LASI-DAD HRS-HCAP 
Age (years)   
     60-64 27.9% -- 
     65-69 29.8% 33.9% 
     70-74 18.9% 25.6% 
     75 + 23.3% 40.6% 
Gender (% female) 52.9% 54.9% 
Education    
     % 0 year (LASI-DAD) 





     % 12 years 3.0% 33.5% 
     % 13+ years 4.9% 50.3% 
Cardiovascular characteristics   
     % systolic blood pressure ≥ 140 mmHg  38.5% 26.2% 
     % diastolic blood pressure ≥ 90 mmHg 22.5% 9.8% 
     % systolic blood pressure ≥ 140 mmHg or diastolic blood  
          pressure ≥ 90 mmHg 
42.5% 28.0% 
     % pulse > 100 beats per minute 6.5% 1.2% 
     % homocysteine > 15 umol/liter 67.1% 22.3% 
     % at risk pro-B-type-natriuretic peptide (proBNP)† 4.5% 5.1% 
Metabolic characteristics   
     % body mass index ≥ 25 kg/m2 29.9% 77.9% 
     % glycosylated hemoglobin ≥ 6.5% 26.8% 15.6% 
     % HDL-cholesterol < 40 mg/dL 39.7% 16.0% 
     % lipoprotein (a) > 30 mg/dL 41.3% -- 
Inflammation characteristics   
     % C-reactive protein > 3 mg/L 36.8% 35.7% 
     % white blood cell count > 11,000/mm3 5.7% 2.8% 
     % albumin < 3.5 g/dL 3.2% 6.1% 
     % uric acid > 7 mg/dL 7.1% -- 
LASI-DAD=the Longitudinal Aging Study in India – Diagnostic Assessment of Dementia Study, 
HRS-HCAP=the Health and Retirement Study Harmonized Cognitive Assessment Protocol 
Project 
aHRS-HCAP includes the sample that never attended school in this category (N=12) 
†proBNP ≥ 900 pg/mL for 60-74 years-old, and ≥ 1,800 pg/mL for ≥ 75 years-old 
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Table 2. Comparison of scores of individual cognitive domains by education levels between the 
Longitudinal Aging Study in India – Diagnostic Assessment of Dementia Study (LASI-DAD) 
and the Health and Retirement Study Harmonized Cognitive Assessment Protocol (HRS-HCAP) 
  Range  LASI-DAD HRS-HCAP 
Years of education  0 1-11 12 13+ ALL 0-11 12 13+  ALL  
10 word list 
immediate recall 
0-30 10.0 13.7 14.3 15.9 11.9 14.8 17.7 19.2 18.0 
10 word list delayed 
recall 
0-10 2.6 4.0 3.8 5.0 3.3 4.0 5.2 5.9 5.4 
10 word list 
recognition 
0-20 15.0 17.4 17.5 18.3 15.2 17.6 18.7 19.1 18.7 
Logical memory 
recognition score 




0-12 4.8 6.3 6.7 7.5 5.6 5.9 7.2 7.8 7.3 
Brave Man delayed 
recall score 
0-12 1.8 4.1 5.1 5.4 3.0 3.6 5.1 6.1 5.3 
MMSE summary 
score 
0-30 20.7 25.8 27.0 28.1 23.3 24.3 26.9 28.1 27.1 
Verbal fluency score 0-43* 10.6 12.9 13.7 15.9 11.9 12.6 16.2 19.2 17.1 
CSID score 0-4 3.3 3.6 3.8 3.8 3.5 3.6 3.7 3.8 3.8 
Raven's test 0-17 6.6 8.8 10.1 11.4 7.8 9.8 12.6 14.2 13.0 
Total cognition score 0-175 82.3 104.9 110.7 121.8 94.2 104.9 123.8 134.5 126.1 
LASI-DAD=the Longitudinal Aging Study in India – Diagnostic Assessment of Dementia Study, HRS-HCAP=the 
Health and Retirement Study Harmonized Cognitive Assessment Protocol Project; MMSE=Mini-mental state 
examination; CSID= community screening instrument for dementia 
*The upper limit is set at maximum number of correct answers provided by respondents. 
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Table 3. Comparison of the relationship between biological and sociodemographic characteristics and total cognitive function scores between LASI-DAD (N=1,865) and HRS-HCAP (N=2,111) 





(Biomarkers +  
age + sex) 
Model 3 
(Biomarkers +  





(Biomarkers +  
age + sex) 
Model 3 
(Biomarkers +  















Cardiovascular characteristics             
   Hypertension (systolic blood 
pressure≥140 mmHg or diastolic 
blood pressure≥90 mmHg) 
-0.1 (1.0) 0.905 0.1 (1.0) 0.926 0.2 (0.9) 0.842 -4.7 (1.0) <.0001 -3.5 (1.0) 0.0005 -2.1 (0.9) 0.0201 
   Pulse -0.2 (0.0) <0.001 -0.2 (0.0) <0.001 -0.1 (0.0) 0.007 -0.0 (0.0) 0.4446 -0.1 (0.0) 0.1521 -0.0 (0.0) 0.8939 
   Homocysteine -0.1 (0.0) 0.048 -0.1 (0.0) 0.012 -0.1 (0.0) 0.019 -0.6 (0.1) <.0001 -0.5 (0.1) <.0001 -0.3 (0.1) 0.0012 
   proBNP (log) -3.3 (0.5) <0.001 -1.9 (0.5) <0.001 -1.4 (0.4) 0.002 -2.8 (0.4) <.0001 -1.6 (0.4) <.0001 -1.4 (0.4) 0.0001 
Metabolic characteristics             
   Body mass index   
   (reference: 18.5-24.9 kg/m2) 
            
      <18.5 kg/m2 -9.3 (1.4) <0.001 -9.5 (1.4) <0.001 -6.7 (1.2) <0.001 -8.0 (5.6) 0.1525 -8.7 (5.4) 0.1059 -7.0 (4.9) 0.1477 
      25.0-29.9 kg/m2 5.6 (1.3) <0.001 6.1 (1.3) <0.001 2.9 (1.2) 0.013 -0.3 (1.3) 0.8061 -0.4 (1.3) 0.7297 -0.1 (1.1) 0.9498 
      ≥30.0 kg/m2 8.4 (2.0) <0.001 9.1 (1.9) <0.001 4.9 (1.7) 0.004 4.0 (1.4) 0.0031 2.8 (1.3) 0.0326 2.8 (1.2) 0.0198 
   Glycosylated hemoglobin 1.5 (0.3) <0.001 1.3 (0.3) <0.001 0.6 (0.3) 0.033 -2.4 (0.5) <.0001 -2.4 (0.5) <.0001 -1.0 (0.5) 0.0318 
   HDL-cholesterol -0.1 (0.1) 0.068 -0.1 (0.1) 0.282 -0.1 (0.0) 0.139 0.1 (0.0) 0.0233 0.0 (0.0) 0.4689 -0.0 (0.0) 0.0649 
   Lipoprotein (a) -0.0 (0.0) 0.669 -0.0 (0.0) 0.707 0.0 (0.0) 0.842 -- -- -- -- -- -- 
Inflammation characteristics             
   C-reactive protein (log) -0.4 (0.4) 0.336 -0.4 (0.4) 0.379 0.0 (0.4) 0.921 0.8 (0.5) 0.1059 0.4 (0.5) 0.4562 0.4 (0.4) 0.3657 
   White blood cell count (log) -0.9 (1.8) 0.628 -1.0 (1.8) 0.563 -0.1 (1.6) 0.977 0.4 (1.7) 0.8285 0.5 (1.6) 0.7512 0.9 (1.5) 0.5584 
   Albumin 9.6 (1.7) <0.001 7.4 (1.7) <0.001 4.4 (1.5) 0.003 5.7 (1.6) 0.0004 4.9 (1.6) 0.0020 2.9 (1.4) 0.0429 
   Uric acid 2.1 (0.4) <0.001 1.6 (0.4) <0.001 0.8 (0.4) 0.028 -- -- -- -- -- -- 
Age (reference: 65-69 year- old)             
   60-64 year-old   3.3 (1.3) 0.011 2.3 (1.1) 0.041   -- -- -- -- 
   70-74 year-old   -4.4 (1.4) 0.002 -4.6 (1.3) <0.001   -3.3 (1.3) 0.0109 -3.2 (1.2) 0.0060 
   ≥ 75 year-old   -10.4 (1.4) <0.001 -11.4 (1.3) <0.001   -11.7 (1.1) <.0001 -11.2 (1.0) <.0001 
Sex (reference: male)             
   Female   -6.4 (1.1) <0.001 0.1 (1.0) 0.926   3.9 (1.0) <.0001 6.5 (0.9) <.0001 
Education (reference: 1-11 years 
for LASI-DAD and 0-11 years for 
HRS-HCAP) 
            
   0 year (LASI)     -19.3 (1.0) <0.001     -- -- 
   12 years     4.5 (2.7) 0.093     13.0 (1.2) <.0001 
   13+ years     13.2 (2.0) <0.001     20.1 (1.2) <.0001 
Household Wealth (reference: 3rd 
Quintile) 
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   1st Quintile     -0.4 (1.4) 0.771     -6.4 (1.3) <.0001 
   2nd Quintile     -2.5 (1.4) 0.075     -1.5 (1.3) 0.2514 
   4th Quintile     2.1 (1.3) 0.108     1.4 (1.3) 0.2804 
   5th Quintile     1.9 (1.4) 0.170     4.5 (1.3) 0.0005 
             
R-square 0.18 0.23 0.41 0.10 0.16 0.32 
LASI-DAD=the Longitudinal Aging Study in India – Diagnostic Assessment of Dementia Study, HRS-HCAP= is the Health and Retirement Study Harmonized Cognitive 
Assessment Protocol Project, proBNP=pro-B-type-natriuretic peptide 
Data are presented as coefficients (standard errors) 
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